It is vital to monitor the liver enzymes, CBC, and kidney functions regularly for patients taking flucytosine. The serum drug concentrations require thorough monitoring for patients receiving high dosages or extended durations of the treatment. The drug concentration is considered non-toxic and adequate at a level below 100 mg/L. With levels above 100 mg/L, toxicity may occur.